diabetes

February 9, 2026

Vanderbilt research uncovers new clue to insulin resistance

The latest findings could lead to more targeted ways to increase insulin-stimulated glucose uptake by muscle and exercise tolerance.

By Bill Snyder
William Russell, MD
January 7, 2026

Longtime pediatric endocrinology director Bill Russell to focus on research, patient care

He has been succeeded on an interim basis by Jill Simmons, MD, professor of Pediatrics and founding director of the Program for Pediatric Metabolic Bone Disorders at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

By Bill Snyder
October 20, 2025

Collaborative forms to better predict, prevent and treat Type 1 diabetes

The new project will map Type 1 diabetes progression using multimodal artificial intelligence alongside a wide range of health data.

September 30, 2025

Alvin Powers honored by Endocrine Society for his research in islet biology and diabetes

This award, which recognizes meritorious contributions to endocrinology research, is one of the Endocrine Society’s prestigious 2026 Laureate Awards.

By Jill Clendening
July 25, 2025

Ravi Shah named to co-direct Vanderbilt Diabetes Center

The Center oversees the NIH-funded Diabetes Research and Training Center, now in its 52nd year of continual operation, which advances innovative investigations related to the cause, prevention, treatment and complications of diabetes and obesity.

By Jill Clendening
From left, Alvin Powers, MD, Joe C. Davis Professor of Biomedical Science and professor of Medicine and Molecular Physiology and Biophysics; Barbara Gisella Carranza Leon, MD, associate professor of Medicine and interim clinical and senior division director of the Division of Diabetes, Endocrinology and Metabolism; and David Nathan, MD, founder and director of the Diabetes Center and Diabetes Research Center at Massachusetts General Hospital. (photo by Susan Urmy)
April 23, 2025

Top scientist shares long view on diabetes research and treatment

The number of adults living with diabetes has surpassed 800 million, and the World Health Organization has called the escalating prevalence of Type 2 diabetes an epidemic.

By Jill Clendening
January 22, 2025

Milestone in VUMC-affiliated diabetes screening and research program underscores impact of clinical trials

Screening and clinical trials are further advancing research to develop therapies that delay or prevent the progression to clinical disease in people at risk of developing Type 1 diabetes.
By Evan Dorian
December 18, 2024

Leading GLP-1 expert shares insights on groundbreaking drugs for glucose control, weight loss

Drucker and his team study the molecular biology and physiology of the GLP-1 and GLP-2 molecules that regulate glucose metabolism, insulin secretion and energy balance.
By Jill Clendening
November 12, 2024

GLP-1 medicines are focus of Discovery Lecture on Nov. 21

Daniel Drucker, MD, a pioneering scientist whose research contributed to the development of the blockbuster GLP-1 medicines used to treat diabetes and obesity, was listed by TIME magazine as one of the 100 Most Influential People of 2024.
By Leigh MacMillan
October 25, 2024

Blockbuster obesity drugs also may slow kidney disease

The report supports previous clinical trials that found the GLP-1 receptor agonist drug semaglutide reduced kidney disease progression in patients with Type 2 diabetes.
By Bill Snyder
October 16, 2024

Study seeks to improve brain health in children with Type 1 diabetes

Children with Type 1 diabetes are at increased risk for neurocognitive complications. Vanderbilt University Medical Center has been selected as one of 11 clinical centers in the United States to evaluate children newly diagnosed with Type 1 diabetes for neurocognitive outcomes.
By Jessica Pasley
July 25, 2024

New study to explore infection response in diabetes

With a $3 million research grant, Henrique Serezani will investigate how altered metabolism in diabetes affects inflammation and sepsis.
By Paul Govern
July 18, 2024

Unhealthy sleep linked to diabetes across several populations

Persistently unhealthy sleep, either not enough or too much, is associated with a significantly increased risk of Type 2 diabetes in a racially and economically varied adult population, an international team of researchers has reported.
By Bill Snyder